Subscribe to Newsletter
Business & Regulation Profession

So, You Want to Become a CDMO…

| Sharon Johnson

Looking to pivot your business model to a CDMO service offering? Here’s what to keep in mind.

Business & Regulation Small Molecules

The Lilly and the Kumquat

| Angus Stewart

Eli Lilly’s Loxo Oncology has signed a deal with Yi Liu’s Kumquat Biosciences, targeting novel small molecules for immuno-oncology.

Discovery & Development Digital Technologies

Human Proteins: Now Free with No Ads

| Angus Stewart

Google’s DeepMind has opened its AlphaFold protein structure database to the world.

Manufacture Drug Discovery

Bringing Certainty to CAR T-Cell Discovery

| Jim Ross

How can we maximize the potential and production of potentially life-saving therapies?

Discovery & Development COVID-19

Throwing Down the Single-Jab Gauntlet

| Angus Stewart

Crowdsourcing initiative searches for a single-shot MRNA COVID-19 vaccine.

Business & Regulation Profession

Leadership Star

Sitting Down With… Andrew Moore, General Manager of Pfizer CentreOne.

Business & Regulation Biosimilars

What Lies Ahead for Biosimilars?

| Stephanie Vine

Sandoz’s Pierre Bourdage talks to us about biosimilars and how uptake can be boosted.

Manufacture Process Control

Sustainability in Bacterial Endotoxin Testing (BET) – A Holistic Approach to Conservation and Recombinant Technology

| Veronika S Wills

How a holistic approach to horseshoe crab sustainability will allow the industry to maintain stocks while protecting patients.

Business & Regulation Analytical Science

AI Reunites Pharma with Mother Nature

| Stephanie Vine, Angus Stewart

Can AI facilitate a grand comeback for medicines sourced from Mother Nature?

Business & Regulation Supply Chain

Getting it Right from the Start: Simulation Optimizes Supply Chain Planning for Clinical Trials

| Benedict Hirth

Clinical supply chains are inherently dynamic and ambiguous, contributing to a high degree of uncertainty.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register